13F Data
13F filer · CIK 1634557

Woodford Investment Management Ltd

London, X0 · filing since Q4 2014 · last filing Jan 27, 2020
Reported value
$0
$-310.1M vs prior
Positions
1
New / sold out
1 / 3
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $310.1M
Top-10 weight
–

Biggest buys vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
NewN/A0––

Biggest sells vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
Sold outTHERAVANCE BIOPHARMA INC-11,350,719-100.0%$-221.1M
Sold outEVOFEM BIOSCIENCES INC-12,496,222-100.0%$-63.0M
Sold outAUTOLUS THERAPEUTICS PLC-2,095,127-100.0%$-26.0M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2014: $466.1MQ1 2015: $704.3MQ2 2015: $1.3BQ3 2015: $1.7BQ4 2015: $2.3BQ1 2016: $2.2BQ2 2016: $2.1BQ3 2016: $2.5BQ4 2016: $2.1BQ1 2017: $2.4BQ2 2017: $2.7BQ3 2017: $2.2BQ4 2017: $1.5BQ1 2018: $1.1BQ2 2018: $824.7MQ3 2018: $1.3BQ4 2018: $1.2BQ1 2019: $1.2BQ2 2019: $591.2MQ3 2019: $310.1MQ4 2019: $0
Q4 2014Q4 2019

Holdings · Q4 2019

#SecuritySharesValueWeight
1N/AN/A0$0–